Acer Therapeutics Inc (NASDAQ:ACER)

19.77
Delayed Data
As of Apr 26
 +0.87 / +4.60%
Today’s Change
5.70
Today|||52-Week Range
22.63
+42.74%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues1.3M2.6M2.9M0.00
 
 
 
 
Depreciation And Amortization387.8K351.4K238.1K4.0K
 
 
 
 
 
 
Operating ExpensesGross Income-------4.0K
 
 
General Expenses16.0M14.3M9.6M13.9M
 
 
 
 
 
Research And Development12.1M10.0M6.5M8.7M
 
 
 
 
 
Total Operating Expenses16.3M14.6M9.9M13.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-15.1M-12.1M-7.0M-13.9M
 
 
 
 
 
Extraordinary Charge0.000.00-1.0M0.00
 
 
Interest Expense On Debt2.0K2.3K3.3K245.1K
 
 
 
 
 
Other Expenses2.2K67.5K8.3K-16.1K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-15.1M-12.0M-8.0M-14.2M
 
 
 
 
 
Net Income-15.1M-12.0M-8.0M-14.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS335.8K565.3K--3.7M
 
 
 
 
Shares To Calculate EPS Diluted335.8K565.3K--3.7M
 
 
 
 
 
Earnings Per ShareEPS-$44.74-$21.23---$3.84
 
 
 
 
EPS Diluted-$44.74-$21.23---$3.84